Pacira Pharma (PCRX) Set to Join S&P SmallCap 600 (Earlier)

Pacira BioSciences Inc. (NASD: PCRX) will replace Shutterfly Inc. (NASD: SFLY) in the S&P SmallCap 600 effective prior to the open of trading on Monday, September 30. Apollo Global Management Inc. (NYSE: APO) is acquiring Shutterfly in a transaction expected to be completed tomorrow pending final conditions.

Pacira BioSciences provides non-opioid pain management and regenerative health solutions for health care practitioners and their patients. Headquartered in Parsippany, NJ, the company will be added to the S&P SmallCap 600 GICS (Global Industry Classification Standard) Pharmaceuticals Sub-Industry index.

Following is a summary of the change:

You May Also Be Interested In

• Agroz Inc. renames shares, adopts dual-class structure
• Gold Resource set to lose Russell 2000 index eligibility after merger
• Energy Vault names BlackRock veteran Nitin Dahiya as CFO